We are live on ! Find out more

6 hedge funds and large institutions have $605K invested in Daxor in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.11% more ownership

Funds ownership: 3.38% → 3.49% (+0.11%)

14% less funds holding

Funds holding: 7 → 6 (-1)

15% less capital invested

Capital invested by funds: $715K → $605K (-$110K)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$1.43K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$14.8K
2
UBS Group
UBS Group
Switzerland
-$24

DXR Hedge Fund Activity: Q4 2017 in Review

6 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q4 2017, worth a combined $605K — down 15% from $715K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of DXR and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.

The largest buyer was Renaissance Technologies, adding an estimated $1.43K. The largest seller was Vanguard Group, cutting an estimated $14.8K.

  • 6 institutional investors held Daxor (DXR) as of Q4 2017, down from 7 in Q3 2017.
  • Funds reported $605K of Daxor stock for Q4 2017, down 15% quarter-over-quarter.
  • 0 funds opened new Daxor positions in Q4 2017 and 1 closed out, a net change of -1 holder.
  • The largest Daxor buyer in Q4 2017 was Renaissance Technologies, an estimated $1.43K added.
  • The largest Daxor seller in Q4 2017 was Vanguard Group, an estimated $14.8K sold.

Based on aggregated 13F filings for Q4 2017.